Pramipexole in Out-patients With Idiopathic Restless Legs Syndrome (IRLS)

PHASE3CompletedINTERVENTIONAL
Enrollment

306

Participants

Timeline

Start Date

April 30, 2008

Primary Completion Date

June 30, 2009

Study Completion Date

June 30, 2009

Conditions
Restless Legs Syndrome
Interventions
DRUG

Pramipexole

DRUG

Placebo

Trial Locations (16)

Unknown

248.630.04 Boehringer Ingelheim Investigational Site, Beijing

248.630.05 Boehringer Ingelheim Investigational Site, Beijing

248.630.06 Boehringer Ingelheim Investigational Site, Beijing

248.630.07 Boehringer Ingelheim Investigational Site, Beijing

248.630.08 Boehringer Ingelheim Investigational Site, Beijing

248.630.15 Boehringer Ingelheim Investigational Site, Guangzhou

248.630.14 Boehringer Ingelheim Investigational Site, Haerbin

248.630.10 Boehringer Ingelheim Investigational Site, Hangzhou

248.630.09 Boehringer Ingelheim Investigational Site, Nanjing

248.630.12 Boehringer Ingelheim Investigational Site, Qingdao

248.630.01 Boehringer Ingelheim Investigational Site, Shanghai

248.630.02 Boehringer Ingelheim Investigational Site, Shanghai

248.630.03 Boehringer Ingelheim Investigational Site, Shanghai

248.630.16 Boehringer Ingelheim Investigational Site, Suzhou

248.630.13 Boehringer Ingelheim Investigational Site, Wuhan

248.630.11 Boehringer Ingelheim Investigational Site, Xian, Shanxi Province

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY